Scotland G, Tsehaye M, Styles C, Logue J, et al. Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trial. Diabet Med 2025 Jul 3:e70098. doi: 10.1111/dme.70098.
PMID: 40607724